Avalo Therapeutics Appoints Jennifer Riley as Chief Strategy Officer
| AVTX Stock | USD 6.75 0.02 0.30% |
Slightly above 61% of Avalo Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Avalo Therapeutics suggests that many traders are alarmed. Avalo Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Avalo Therapeutics' earnings reports, geopolitical events, and overall market trends.
Avalo |
WAYNE, Pa. and ROCKVILLE, Md., Jan. 02, 2025 -- Avalo Therapeutics, Inc. , a clinical stage biotechnology company focused on the treat
Read at gurufocus.com
 |
Avalo Therapeutics Fundamental Analysis
We analyze Avalo Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Avalo Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Avalo Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Flow From Operations
Cash Flow From Operations Comparative Analysis
Avalo Therapeutics is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Avalo Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Avalo Therapeutics stock to make a market-neutral strategy. Peer analysis of Avalo Therapeutics could also be used in its relative valuation, which is a method of valuing Avalo Therapeutics by comparing valuation metrics with similar companies.
Peers
Avalo Therapeutics Related Equities
| ANAB | AnaptysBio | 6.50 | ||||
| AVTE | Aerovate Therapeutics | 6.17 | ||||
| GPCR | Structure Therapeutics | 4.73 | ||||
| BNTC | Benitec Biopharma | 4.56 | ||||
| ACRV | Acrivon Therapeutics, | 4.14 | ||||
| ALZN | Alzamend Neuro | 2.59 | ||||
| VRAX | Virax Biolabs | 1.87 | ||||
| CGEM | Cullinan Oncology | 1.56 | ||||
| ACLX | Arcellx | 0.14 | ||||
| PMVP | Pmv Pharmaceuticals | 1.44 | ||||
| EWTX | Edgewise Therapeutics | 1.72 | ||||
| ANEB | Anebulo Pharmaceuticals | 1.85 | ||||
| CCCC | C4 Therapeutics | 2.28 | ||||
| MLYS | Mineralys Therapeutics, | 2.74 | ||||
| IPSC | Century Therapeutics | 3.19 | ||||
| MOLN | Molecular Partners | 4.30 | ||||
| ALXO | Alx Oncology | 5.17 |
Additional Tools for Avalo Stock Analysis
When running Avalo Therapeutics' price analysis, check to measure Avalo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avalo Therapeutics is operating at the current time. Most of Avalo Therapeutics' value examination focuses on studying past and present price action to predict the probability of Avalo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avalo Therapeutics' price. Additionally, you may evaluate how the addition of Avalo Therapeutics to your portfolios can decrease your overall portfolio volatility.